| scholarly article | Q13442814 |
| P50 | author | Rick Richardson | Q43207421 |
| P2093 | author name string | Jacquelyn Cranney | |
| Lana Ledgerwood | |||
| P433 | issue | 3 | |
| P921 | main subject | cycloserine | Q418508 |
| P304 | page(s) | 505-513 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Behavioral Neuroscience | Q4880707 |
| P1476 | title | D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement | |
| P478 | volume | 118 |
| Q38851779 | A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission |
| Q39783270 | A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects |
| Q30585383 | A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans |
| Q35112659 | Aberrant learning and memory in addiction |
| Q50756425 | Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. |
| Q39427245 | Acute, but not chronic, exposure to d-cycloserine facilitates extinction and modulates spontaneous recovery of a conditioned taste aversion |
| Q43272463 | Alterations of excitatory transmission in the lateral amygdala during expression and extinction of fear memory |
| Q47658025 | Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear |
| Q30375098 | An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials |
| Q36369578 | An Update on Memory Reconsolidation Updating |
| Q43186100 | An fMRI study examining effects of acute D-cycloserine during symptom provocation in spider phobia |
| Q35781150 | An unconditioned stimulus retrieval extinction procedure to prevent the return of fear memory |
| Q46681201 | Augmentation of fear extinction by D-cycloserine is blocked by proteasome inhibitors |
| Q24684778 | Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine |
| Q30358603 | Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. |
| Q30474984 | Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory |
| Q42263567 | Behavioural memory reconsolidation of food and fear memories |
| Q36243660 | Cannabinoid facilitation of fear extinction memory recall in humans |
| Q37649879 | Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans |
| Q35043180 | Cognitive enhancers for facilitating drug cue extinction: insights from animal models |
| Q36498685 | Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders |
| Q36551965 | Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes |
| Q37568031 | Common influences of non-competitive NMDA receptor antagonists on the consolidation and reconsolidation of cocaine-cue memory |
| Q30450633 | Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm |
| Q24658464 | Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network |
| Q34350942 | D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders |
| Q42326066 | D-Serine facilitates the effectiveness of extinction to reduce drug-primed reinstatement of cocaine-induced conditioned place preference |
| Q24626679 | D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning |
| Q28266461 | D-cycloserine effects on extinction of conditioned responses to drug-related cues |
| Q30479274 | D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms |
| Q41433830 | D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome |
| Q34468685 | Different mechanisms of fear extinction dependent on length of time since fear acquisition |
| Q40174485 | Differential acquisition, extinction, and reinstatement of conditioned suppression in mice. |
| Q37553161 | Early postnatal stress and neural circuit underlying emotional regulation |
| Q50628293 | Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial. |
| Q36901973 | Effect of D-cycloserine in conjunction with fear extinction training on extracellular signal-regulated kinase activation in the medial prefrontal cortex and amygdala in rat. |
| Q36153036 | Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers |
| Q40974359 | Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice |
| Q43232329 | Effects of reinforcement schedule on facilitation of operant extinction by chlordiazepoxide |
| Q46934826 | Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD. |
| Q36363614 | Emotional learning and glutamate: translational perspectives |
| Q45215137 | Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear |
| Q34017493 | Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder |
| Q30493574 | Enhancing exposure-based therapy from a translational research perspective |
| Q36948459 | Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial |
| Q30382252 | Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data |
| Q50777488 | Extinction retention predicts improvement in social anxiety symptoms following exposure therapy. |
| Q48433093 | Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace. |
| Q48607780 | Extract of Ginkgo biloba EGb761 facilitates extinction of conditioned fear measured by fear-potentiated startle |
| Q56784855 | Facilitation of Extinction of Conditioned Fear by D-Cycloserine |
| Q30475516 | Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear |
| Q28682506 | From resilience to vulnerability: mechanistic insights into the effects of stress on transitions in critical period plasticity |
| Q39291412 | Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder |
| Q48394251 | Glutamate NMDA receptors within the amygdala participate in the modulatory effect of glucocorticoids on extinction of conditioned fear in rats |
| Q30477927 | Glutamate receptors in extinction and extinction-based therapies for psychiatric illness |
| Q30456148 | How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. |
| Q38100425 | How to erase memory traces of pain and fear |
| Q34022949 | Impaired extinction retention in adolescent rats: effects of D-cycloserine |
| Q48859271 | Intraamygdala infusion of fibroblast growth factor 2 enhances extinction and reduces renewal and reinstatement in adult rats |
| Q34277629 | Learning to forget: manipulating extinction and reconsolidation processes to treat addiction |
| Q28278209 | Mechanisms of fear extinction |
| Q37863149 | Modulation of fear memory by retrieval and extinction: a clue for memory deconsolidation |
| Q48616635 | NMDA Partial agonist reverses blocking of extinction of aversive memory by GABA(A) agonist in the amygdala |
| Q26853333 | Neural and cellular mechanisms of fear and extinction memory formation |
| Q30458551 | Neurobiological correlates of cognitions in fear and anxiety: a cognitive-neurobiological information-processing model |
| Q64240028 | Neurochemical and molecular mechanisms underlying the retrieval-extinction effect |
| Q38808613 | New Learning and Unlearning: Strangers or Accomplices in Threat Memory Attenuation? |
| Q33740875 | Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior |
| Q43292774 | Pharmacological discrimination of extinction and reconsolidation of contextual fear memory by a potentiator of AMPA receptors |
| Q34721646 | Pharmacological enhancement of drug cue extinction learning: translational challenges |
| Q30462825 | Pharmacological enhancement of fear reduction: preclinical models. |
| Q30480038 | Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy |
| Q27006437 | Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders |
| Q30476116 | Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear |
| Q37563543 | Psychotherapy for obsessive-compulsive disorder |
| Q50633422 | Reconsolidation or extinction: transcription factor switch in the determination of memory course after retrieval. |
| Q47141386 | Reinstatement of contextual conditioned anxiety in virtual reality and the effects of transcutaneous vagus nerve stimulation in humans. |
| Q48625979 | Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors. |
| Q30466738 | Seeking a spotless mind: extinction, deconsolidation, and erasure of fear memory |
| Q37634056 | Single prolonged stress: toward an animal model of posttraumatic stress disorder |
| Q41194121 | Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodeling. |
| Q28265467 | Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice |
| Q34122994 | Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters |
| Q44988100 | The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine |
| Q37690425 | The Efficacy of Augment of D-Cycloserine and Cognitive-behavioral Therapy on Adolescent with one Type of Anxiety Disorders: A Double-blind Randomized Controlled Trial |
| Q46434328 | The facilitative effects of D-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement |
| Q31029023 | The role of glutamate in anxiety and related disorders |
| Q91117928 | The role of prediction error and memory destabilization in extinction of cued-fear within the reconsolidation window |
| Q50638340 | The role of the dorsal hippocampus on the Ginkgo biloba facilitation effect of fear extinction as assessed with fear-potentiated startle. |
| Q33988524 | The study of fear extinction: implications for anxiety disorders |
| Q89958362 | Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders |
| Q30428273 | Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety |
| Q35787895 | d-cycloserine reverses the detrimental effects of stress on learning in females and enhances retention in males |
Search more.